Format

Send to

Choose Destination
Breastfeed Med. 2015 Mar;10(2):92-5. doi: 10.1089/bfm.2014.0086. Epub 2015 Feb 3.

Colchicine use during breastfeeding.

Author information

1
1 Neonatal Intensive Care Unit, Schneider Children's Medical Center of Israel , Petah Tiqva, Israel .

Abstract

OBJECTIVE:

This study evaluated the outcome of infants exposed to colchicine during lactation.

SUBJECTS AND METHODS:

A prospective observational cohort study design was used. Mothers who contacted Beilinson Teratology Information Service (BELTIS) regarding use of colchicine while breastfeeding were followed up by phone interview. Data on lactation, neonatal symptoms, and outcome 1-3 years after initial consultation were obtained. Mothers breastfeeding while taking colchicine (n=37) and their infants (n=38) were compared with a matched control group of mothers using a drug known to be safe during lactation (n=75) and their infants (n=76).

RESULTS:

Follow-up was obtained for 59 of 76 (78%) women who contacted BELTIS regarding use of colchicine. Of the 59 women, 37 breastfed while taking colchicine, five did not take colchicine, 16 did not breastfeed, and one declined to participate. The mean duration of breastfeeding was similar in both groups. Adverse neonatal symptoms were seen in three of 38 colchicine-exposed infants versus four of 76 of control group infants (p=0.68). Delayed development or neurological abnormalities were seen in two infants in both study groups (p=0.60). None of the colchicine-exposed infants showed abnormal growth.

CONCLUSIONS:

No increase in adverse long-term outcomes was found in colchicine-exposed breastfed infants. Our data support continuation of breastfeeding in women treated with colchicine.

PMID:
25646562
DOI:
10.1089/bfm.2014.0086
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center